These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5055491)

  • 21. [Fate of patients with pulmonary tuberculosis and secondary drug resistance to the major drugs].
    Kost A
    Gruzlica; 1969 Nov; 37(11):997-1002. PubMed ID: 5368630
    [No Abstract]   [Full Text] [Related]  

  • 22. [The morphology of pulmonary tuberculosis in comparison with bacterioscopic data in prolonged antibacterial therapy].
    Raskina ES; Vavilin GI
    Probl Tuberk; 1968; 46(6):52-7. PubMed ID: 5710820
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the open negative syndrome resulting from chemotherapy with secondary anti-tuberculosis agents.
    Kimura Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:71-6. PubMed ID: 5298482
    [No Abstract]   [Full Text] [Related]  

  • 24. [Research on primary resistance to antitubercular agents and antibiotics in the antituberculosis centers].
    Santi GM; Poggiopollini M
    Minerva Med; 1967 Jun; 58(49):2285-8. PubMed ID: 6029301
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of late results of treatment of patients operated on for pulmonary tuberculosis and those refusing surgery].
    Jaworski J
    Gruzlica; 1971 Sep; 39(9):905-12. PubMed ID: 5111367
    [No Abstract]   [Full Text] [Related]  

  • 26. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pulmonary tuberculosis and primary bacterial resistance to antibacillary drugs].
    Cazes M
    Torax; 1967 Dec; 16(4):222-30. PubMed ID: 5620686
    [No Abstract]   [Full Text] [Related]  

  • 28. [Tuberculosis problems from the viewpoint of the pathologist].
    Oudet P
    Internist (Berl); 1966 Oct; 7(10):487-98. PubMed ID: 4869400
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
    Ferraro U; Briccarello L; Vercellino E
    G Ital Mal Torace; 1968; 22(4):195-201. PubMed ID: 5743001
    [No Abstract]   [Full Text] [Related]  

  • 30. [Restorative processes in the chemotherapy of destructive pulmonary tuberculosis].
    Novoselova VP; Ertli AA
    Probl Tuberk; 1979 Apr; (4):59-63. PubMed ID: 441059
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the morphological diagnosis of drug-resistant pulmonary tuberculosis].
    Ziuzia IuR; Lepekha LN; Gedymin LE; Burtseva SA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (10):56-60. PubMed ID: 17139834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Retreatment of lung tuberculosis].
    Iwasaki T
    Naika; 1966 Sep; 18(3):487-93. PubMed ID: 5975918
    [No Abstract]   [Full Text] [Related]  

  • 33. The pathogenesis and treatment of isoniazid-resistant tuberculosis in 13 patients.
    Greenberg HB
    J La State Med Soc; 1969 Dec; 121(12):381-5. PubMed ID: 5368395
    [No Abstract]   [Full Text] [Related]  

  • 34. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs].
    Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W
    Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of treatment in new cases of pulmonary tuberculosis registered in 1963 at the Antitubercular Dispensary of the Wola District of Warsaw].
    Rose A
    Gruzlica; 1967 Dec; 35(12):1251-6. PubMed ID: 6081907
    [No Abstract]   [Full Text] [Related]  

  • 37. [Residual pulmonary lesions after standard chemotherapy of advanced cavernous tuberculosis].
    Krychniak W; Pszonicka A; Zajaczkowska J
    Gruzlica; 1967 Jun; 35(6):519-27. PubMed ID: 6051994
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cavity dynamics in tuberculosis--attempt at a mathematical description].
    Meller AJ; Schwabe KH
    Prax Klin Pneumol; 1984 Nov; 38(11):491-8. PubMed ID: 6514673
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of salbutamol and aspirin on pulmonary ventilation and hemodynamics in patients with infiltrative tuberculosis].
    Vizel' AA; Iaushev MF
    Probl Tuberk; 1991; (5):29-31. PubMed ID: 1924238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
    Gorokhova TV
    Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.